Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Short stature, Brachydactyly, Postaxial hand polydactyly, and Acetabular spurs and others. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 2 | Postaxial hand polydactyly, Postaxial foot polydactyly |
DYNLT2B encodes dynein light chain Tctex-type 2B (142 aa). Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system. Highest expression in Testis (48.9 TPM) and Brain Frontal Cortex BA9 (24.7 TPM).
Short-rib thoracic dysplasia 17 with or without polydactyly is associated with mutations in the DYNLT2B gene on chromosome 3.
DYNLT2B is classified as a druggable target with score 0.0.
Genetic testing for DYNLT2B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for short-rib thoracic dysplasia 17 with or without polydactyly has been reported in the published literature.
Phenotype severity distribution: 9 common features.
No clinical trials have been registered for short-rib thoracic dysplasia 17 with or without polydactyly.
200 publications have been identified in PubMed for short-rib thoracic dysplasia 17 with or without polydactyly. Research spans Case Report / Case Series (39%), Basic Science / Preclinical (21%), and Epidemiology / Natural History (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 75 | 39% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:33 AM UTC
Online Mendelian Inheritance in Man
1 |
Short stature |
Laboratory research |
40 |
21% |
Disease patterns and progression | 35 | 18% |
Research summaries | 26 | 13% |
Other research | 5 | 3% |
Testing and diagnosis research | 5 | 3% |
Clinical study results | 5 | 3% |
New treatment approaches | 3 | 2% |
Akhila P (2026). [PMID: 41611321](https://pubmed.ncbi.nlm.nih.gov/41611321/). *BMJ Case Rep*. [Case Report / Case Series]
Doronin IV (2026). [PMID: 40444474](https://pubmed.ncbi.nlm.nih.gov/40444474/). *Anat Rec (Hoboken)*. [Basic Science / Preclinical]
Tang J (2026). [PMID: 42095020](https://pubmed.ncbi.nlm.nih.gov/42095020/). *Front Genet*. [Basic Science / Preclinical]
Khan H (2026). [PMID: 41786235](https://pubmed.ncbi.nlm.nih.gov/41786235/). *Bone*. [Basic Science / Preclinical]
Romo-Aguas JC (2026). [PMID: 42022048](https://pubmed.ncbi.nlm.nih.gov/42022048/). *Ophthalmol Sci*. [Epidemiology / Natural History]
Ürkmez MF (2026). [PMID: 41499068](https://pubmed.ncbi.nlm.nih.gov/41499068/). *CEN Case Rep*. [Basic Science / Preclinical]
Lu M (2026). [PMID: 42252464](https://pubmed.ncbi.nlm.nih.gov/42252464/). *J Orthop Surg Res*. [Clinical Trial Publication]
Abola MV (2026). [PMID: 41037671](https://pubmed.ncbi.nlm.nih.gov/41037671/). *J Pediatr Orthop*. [Diagnostic / Biomarker]
Melnik E (2026). [PMID: 41744514](https://pubmed.ncbi.nlm.nih.gov/41744514/). *Clin Pract*. [Case Report / Case Series]
Mendenhall SD (2026). [PMID: 40489747](https://pubmed.ncbi.nlm.nih.gov/40489747/). *Plast Reconstr Surg*. [Epidemiology / Natural History]